Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hologic makes more cuts in drive for profitability

This article was originally published in Clinica

Executive Summary

Becton Dickinson's shares fell from $36.70 to around $32.20 in the period after the company released its fourth-quarter and full-year results and forecast for 2002. The company says it is looking at options for increasing operating efficiency, including possibly "a smaller scale restructuring of manufacturing facilities in the BD medical systems segment". It is also considering divesting some smaller business units. Becton expects earnings-per-share growth of around 10% for 2002. "We continue to deliver revenue and earnings growth in line with the commitments we have made to our shareholders," said Edward Ludwig, CEO. The company's medical device unit had sales of $537 million in the quarter, up 7%. Total safety-engineered products' sales were $253 million in the year, a 55% increase. Becton's clinical laboratory solutions unit had sales of $295 million, a 10% increase.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074116

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel